BioXcel starts mid-stage BXCL501 trial for treatment of delirium related agitation
25 February 2021 - 11:16PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
BioXcel Therapeutics (NASDAQ:BTAI)
Historical Stock Chart
From Apr 2024 to May 2024
BioXcel Therapeutics (NASDAQ:BTAI)
Historical Stock Chart
From May 2023 to May 2024